Alignment Healthcare, Inc. (ALHC) P/E Ratio History
Deep ValueTrading at 52.9x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2026–2026
Loading P/E history...
P/E Ratio Analysis
As of November 8, 2026, Alignment Healthcare, Inc. (ALHC) trades at a price-to-earnings ratio of 52.9x, with a stock price of $7.34 and trailing twelve-month earnings per share of $0.14.
The current P/E is 59% below its 5-year average of 127.9x. Over the past five years, ALHC's P/E has ranged from a low of 63.4x to a high of 192.8x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 24.6x, ALHC trades at a 115% premium to its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 196.0x.
Relative to the broader market, ALHC commands a significant premium over the S&P 500 median P/E of 21.8x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ALHC DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ALHC Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
ALHC P/E vs Peers
Health Insurers peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $34B | 23.6 | - | -316% | |
| $107B | 9.8 | - | -62% | |
| $52B | 42.4 | - | -1% | |
| $92B | 18.0 | 2.61 | -2% | |
| $8B | 12.4 | - | -1866% | |
| $2B | 216.1 | - | -94% | |
| $37B | 8.4Lowest | 0.29Best | +4%Best | |
| $358B | 22.4 | - | -15% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
ALHC Historical P/E Data (2026–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q3 | Sep 30 2026 | $8.16 | $0.13 | 63.4x | -50% |
| FY2026 Q2 | - | $23.81 | $0.19 | 127.6x | -0% |
| FY2026 Q1 | - | $17.62 | $0.09 | 192.8x | +51% |
Average P/E for displayed period: 127.9x
ALHC Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10-year return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ALHC — Frequently Asked Questions
Quick answers to the most common questions about buying ALHC stock.
What is ALHC's P/E ratio?
Alignment Healthcare, Inc. (ALHC) trailing twelve-month P/E ratio is 52.9x, based on TTM diluted EPS of $0.14. The 5-year average P/E is 127.9x and the historical range spans 63.4x to 192.8x.
Is ALHC stock overvalued or undervalued?
ALHC trades at 52.9x P/E, below its 5-year average of 127.9x. At the 0th percentile of its historical range (63.4x–192.8x), the stock is priced at a discount to its own history.
Is ALHC stock expensive?
No, ALHC is not expensive on a historical basis. The current P/E of 52.9x is below the 5-year average of 127.9x and sits at the 0th percentile of its valuation range.
What is ALHC's historical P/E range?
Over the past 5 years, ALHC's P/E ratio has ranged from 63.4x to 192.8x, with a median of 127.6x and an average of 127.9x. The current P/E of 52.9x places the stock at the 0th percentile of this range. Full historical data spans 2026–2026.
How does ALHC's P/E compare to the S&P 500?
ALHC trades at 52.9x P/E versus the S&P 500 median of 21.8x. The 143% premium to the market typically reflects higher expected earnings growth or quality.
How does ALHC's valuation compare to Healthcare peers?
Alignment Healthcare, Inc. P/E of 52.9x compares to the Healthcare sector median of 24.6x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is ALHC's PEG ratio?
ALHC PEG ratio is N/A, based on a P/E of 52.9x and EPS growth of 99.4%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is ALHC's earnings yield?
ALHC earnings yield is 1.89%, the inverse of its 52.9x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.